Istaroxime Infusion for 24 Hours in Chinese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Healthy
Interventions
DRUG

istaroxime

8 subjects in 0.25ug/kg/min group were administrated Istaroxime + 0.9% NS fo12 subjects in 0.5ug/kg/min or 1.0 ug/kg/min group randomly received Istaroxime placebo + 0.9% NS (2 subjects), 0.9% NS alone (2 subjects) and Istaroxime + 0.9% NS (8 subjects).

DRUG

9% Saline (NS)

infusion for 24 hours

Trial Locations (1)

100071

The 307th hospital of chinese People's liberation army, Beijing

Sponsors
All Listed Sponsors
collaborator

CVie Therapeutics Co. Ltd.

INDUSTRY

lead

Lee's Pharmaceutical Limited

INDUSTRY

NCT02477449 - Istaroxime Infusion for 24 Hours in Chinese Healthy Volunteers | Biotech Hunter | Biotech Hunter